AM2019 ECON03 eContouring for Oligometastatic SBRT
This session will involve the collaboration of three radiation oncologists with expertise in spine and lung SBRT. We will review the anatomy of the lung and spine including adjacent critical structures. With regards to the spine, we will review details of target delineation for intact vertebral bodies and then apply these same concepts to target delineation for post-operative spine SBRT in our example case. For the lung, we will review the chest anatomy and contouring technique of a central/ultracentral lung tumor. Throughout the session, existing consensus contouring guidelines for spinal metastases will be reviewed. Relevant guidelines for early stage lung cancer lung SBRT will be reviewed with reference to lung oligometastases. The attendees will be provided with the cases as homework prior to the meeting. We will review contouring homework and discuss areas of consensus and controversy. Finally we will review our contours for the same cases and allow students to revise their contours with input from the presenters. Review of select audience contours in comparison to the expert contours will be performed for the purposes of teaching and discussion of acceptable vs. unacceptable deviations.
The meeting is designed to meet the interests of radiation oncologists, radiation dosimetrists, physicists, and residents.
- Identify the anatomic compartments of the spine and apply this knowledge to contour the CTV and PTV for SBRT to both intact and post-operative spine metastases
- Delineate the spinal cord avoidance structure and understand the importance of precise contouring of this organ at risk
- Contour centrally locally lung metastasis and identify the appropriate organs-at-risk in the thorax.
The following persons served as faculty for this activity:
Simon Lo, MB, ChB, FACR, FASTRO is employed at University of Washington Medical Center and receives compensation/remuneration/funding from Elekta.
Kristin Redmond, MD, MPH is employed at Department of Radiation Oncology, Arthur G. James Hospital and receives compensation/remuneration/funding from Accuray, AstraZeneca, and Elekta AB.
Gregory Videtic, MD, CM, FACR, FASTRO, FRCPC, FASTRO is employed at Cleveland Clinic and has nothing to disclose.
Additionally, the Education and CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.